As demand for the new class of GLP-1 weight-loss drugs skyrockets, one thing has stood in the way of many people trying to access them: cost. With a price tag around $1,000 a month for U.S. patients and many insurance companies refusing to cover these drugs for weight loss, patients are often turning to alternatives. In episode two of “Trillion Dollar Shot,” we look at the roadblocks to making these drugs more affordable, concerns that their high cost will negatively impact U.S. insurance systems, and the sometimes risk-laden options people are turning to in desperation. Listen: Trillion Dollar Shot, Episode 1: Birth of a Blockbuster Learn more about your ad choices. Visit megaphone.fm/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from The Journal.
Transcribed and ready to explore now
Medicare, Inc. Part 1: How Insurers Make Billions From Medicare
06 Jun 2025
The Journal.
Deportations Could Upend This Parachute Factory
05 Jun 2025
The Journal.
The Struggle to Get Aid Into Gaza
04 Jun 2025
The Journal.
The Everyday American Who Hustled for North Korea
03 Jun 2025
The Journal.
Stop Making Cents: The End of the Penny
02 Jun 2025
The Journal.
Ron Howard and Brian Grazer on Longevity in Hollywood
01 Jun 2025
The Journal.